Role of Hyaluronan and Nitric Oxide in Tissue Injury and Repair in Idiopathic Pulmonary Arterial Hypertension.

Author(s):  
M Aytekin ◽  
S Haserodt ◽  
S Comhair ◽  
R Dweik
CHEST Journal ◽  
2010 ◽  
Vol 138 (4) ◽  
pp. 805A
Author(s):  
Jose G. Gomez-Arroyo ◽  
Juan P. Sandoval-Jones ◽  
Paulina Ramirez-Neria ◽  
Armando Rodriguez ◽  
Carla Murillo ◽  
...  

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Majid Malekmohammad ◽  
Gert Folkerts ◽  
Babak Sharif Kashani ◽  
Parisa Adimi Naghan ◽  
Zahra Habibi Dastenae ◽  
...  

Following publication of the original article [1], the authors flagged that name of the author ‘Batoul Khoundabi’ had been provided with an incorrect spelling: ‘Batoutl’ was given in place of ‘Batoul’.


2017 ◽  
Vol 2017 (2) ◽  
Author(s):  
Adrian H Chester ◽  
Magdi H Yacoub ◽  
Salvador Moncada

The pathogenesis of pulmonary arterial hypertension remains undefined. Changes in the expression and effects mediated by a number of vasoactive factors have been implicated to play a role in the onset and progression of the disease. The source of many of these mediators, such as nitric oxide (NO), prostacyclin and endothelin-1 (ET-1), is the pulmonary endothelium. This article focus in the role of nitric oxide in PAH, reviewing the evidence for its involvement in regulation of pulmonary a vascular tone under physiological conditions, the mechanisms by which it can contribute to the pathological changes seen in PAH and strategies for the use of NO as a therapy for treatment of the disease. 


2016 ◽  
Vol 88 (9) ◽  
pp. 65-70
Author(s):  
V A Nevzorova ◽  
E A Kochetkova ◽  
L G Ugay ◽  
Yu V Maistrovskaya ◽  
E A Khludeeva

Aim. To define the role of circulating biomarkers for the metabolism of collagen and intercellular substance and vascular remodeling in the development of osteoporosis (OP) in idiopathic pulmonary arterial hypertension (IPAH). Materials and methods. Functional hemodynamic parameters, bone mineral density (BMD) in the lumbar spine and femoral neck and the serum levels of matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1 (TIMP-1), MMP-9/TIMP-1 complex, C-terminal telopeptide of collagen type 1 (CITP), and endothelin-1 (ET-1) were determined in 27 high-risk IPAH patients and 30 healthy volunteers. Results. OP in IPAH was detected in 50% of the examinees. The serum levels of CITP, MMP-9, TIMP-1, and ET-1 proved to be higher in the high-risk IPAH patients than in the healthy volunteers. There was a direct correlation between BMD and six-minute walk test and an inverse correlation with total pulmonary vascular resistance (TPVR). Serum TMIP-1 levels correlated with cardiac index and TPVR; ET-1 concentrations were directly related to pulmonary artery systolic pressure, cardiac index, and TPVR. Inverse relationships were found between BMD and circulating CITP, MMP-9, TMIP-1, MMP-9/TMIP-1, and ET-1. At the same time, there was only a tendency towards a positive correlation between serum CITP and ET-1 concentrations. Conclusion. The results of the investigation confirm that endothelin system dysregulation plays a leading role in the development of persistent hemodynamic disorders in high-risk IPAH and suggest that it is involved in the development of osteopenic syndrome. Enhanced ET-1 secretion initiates bone loss possibly via activation of connective tissue matrix destruction.


Sign in / Sign up

Export Citation Format

Share Document